Vietnam invites Indian pharma companies to set up units
Advertisement
Kolkata: Vietnam urged Indian pharma companies to set up units in that country as part of the 'Make in Vietnam' initiative, the country's ambassador to India Ton Sinh Thanh said.
"Pharmaceuticals is one of the major items that Vietnam imports from India. Thus, Indian pharmaceuticals companies should set up base there as a part of Make in Vietnam initiative," Thanh said at a session organised by MCC Chamber here.
Thanh said another area in which India could help Vietnam was services.
"The services sector India is very developed and Vietnam has a pool of skilled manpower. There is lot of scope for cooperation between India and Vietnam in the field of services sector. India has a developed services sector," he said.
There was a need for knowledge transfer from India to Vietnam, he said.
Thanh said the Indian government had offered a credit line of $300 million for trade diversification and strengthening of commercial ties between the two countries.
The targeted bilateral trade between the two countries was $15 billion by 2020. In 2014, the bilateral trade was $5.6 billion.
"Pharmaceuticals is one of the major items that Vietnam imports from India. Thus, Indian pharmaceuticals companies should set up base there as a part of Make in Vietnam initiative," Thanh said at a session organised by MCC Chamber here.
Thanh said another area in which India could help Vietnam was services.
"The services sector India is very developed and Vietnam has a pool of skilled manpower. There is lot of scope for cooperation between India and Vietnam in the field of services sector. India has a developed services sector," he said.
There was a need for knowledge transfer from India to Vietnam, he said.
Thanh said the Indian government had offered a credit line of $300 million for trade diversification and strengthening of commercial ties between the two countries.
The targeted bilateral trade between the two countries was $15 billion by 2020. In 2014, the bilateral trade was $5.6 billion.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.